Szekeres David Leslie
SEC CIK 1602459 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | EVP, COO | 33.8K | — | — | 21 | 2021-04-30 | 2023-07-13 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Szekeres David Leslie made no open-market trades at HRTX in the last 12 months.
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-17 | 2023-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $1.31 | -2,012 | 33.8K | -6% | -$2,636 |
| DM | 2023-07-17 | 2023-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 35.8K | +19% | — |
| DM | 2023-04-17 | 2023-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 27.4K | +27% | — |
| D | 2023-04-17 | 2023-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $2.88 | -2,012 | 30.0K | -6% | -$5,795 |
| D | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $3.17 | -2,012 | 26.1K | -7% | -$6,378 |
| D | 2023-01-17 | 2022-10-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | J - Other | $3.27 | +1,654 | 22.3K | +8% | +$5,409 |
| DM | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 28.2K | +26% | — |
| D | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $3.76 | -2,012 | 20.7K | -9% | -$7,565 |
| DM | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 22.7K | +34% | — |
| D | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $3.01 | -2,012 | 16.9K | -11% | -$6,056 |
| DM | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 14.3K | +68% | — |
| D | 2022-07-15 | 2022-04-29 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | J - Other | $3.84 | +1,505 | 13.1K | +13% | +$5,779 |
| DM | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 9,033 | +181% | — |
| D | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $6.07 | -2,012 | 11.6K | -15% | -$12.2K |
| D | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $8.30 | -2,012 | 7,783 | -21% | -$16.7K |
| DM | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +5,814 | 5,231 | New | — |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +1,250 | 4,414 | +40% | — |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $10.55 | -433 | 3,981 | -10% | -$4,568 |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | M - OptEx | — | +1,250 | 3,597 | +53% | — |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | F - Tax | $13.48 | -433 | 3,164 | -12% | -$5,837 |
| D | 2021-07-15 | 2021-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, COO | J - Other | $13.90 | +1,530 | 2,347 | +187% | +$21.3K |
Purchase Sale Sale after option exercise All abbreviations